Marc Suárez‐Calvet

Propagation of Tau Pathology in a Model of Early Alzheimer's Disease

Alix de Calignon, Manuela Polydoro, Marc Suárez‐Calvet et al. · Neuron · 2012 · 1.4K citations · Full text

Life Sciences, Neurobiology, Neuroscience +14

TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis

Gernot Kleinberger, Yoshinori Yamanishi, Marc Suárez‐Calvet et al. · Science Translational Medicine · 2014 · 837 citations

Life Sciences, Cell Biology, Neuroscience +13

Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum

Andréa Lessa Benedet, Marta Milà‐Alomà, Agathe Vrillon et al. · JAMA Neurology · 2021 · 631 citations · Full text

Medicine, Neurology, Neuroscience +17

sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers

Marc Suárez‐Calvet, Gernot Kleinberger, Miguel Ángel Araque Caballero et al. · EMBO Molecular Medicine · 2016 · 530 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detected

Marc Suárez‐Calvet, Thomas K. Karikari, Juan Lantero‐Rodriguez et al. · EMBO Molecular Medicine · 2020 · 414 citations · Full text

Life Sciences, Neurology, Neuroscience +17